Capital Cell

Capital Cell is Europe’s first life sciences equity crowdfunding platform. Traditionally, life sciences investment has only been accessible to a small group of people with a high level of technical expertise and large sums to invest. Capital Cell opens life science investment to everyone by sourcing and screening the most innovative early-stage life science companies, and presenting them to the crowd through a regulated online investment platform. Capital Cell finances companies whose technology is based on biology or healthcare, and uses the crowdsourced expertise of the BioExpert Network to filter the companies being analysed. Capital Cell redefines life science investment, and through supporting scientific innovation, funds projects that change lives.

Additional Information

Investor Type Crowdfund and Online Investment Platforms
Services Provided Live Pitch Presentations, Online Showcase
Investment Stage Seed, Start-Up, Early Stage VC
Investment Opportunities Yes
Regions Covered National, Continental Europe
Investment Range Less than £150k, £150k - £250k, £250k - £500k, £500k - £1m, £1m - £3m
Sectors Considered Healthcare, Med Tech and Digital Health, Life Sciences
Company Success Fee Capital Cell charges a success fee of 5-7.5% (depending on the amount of capital raised). We also charge a listing fee of £750, but the company analysis and BioExpert Network Fast Market Feedback report is free of charge.

Contact Form

Stay informed

  • This field is for validation purposes and should be left unchanged.